Drawing for ORALHEP

USPTO serial 79036480

ORALHEP

Reviewed by CopyMark Law Group

Status 401
Filing date
Status date
Registration date
—
Examiner
CHHINA, KARANENDRA S
Law office
TMEG LAW OFFICE 105

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ORALHEP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

William C. Wright

William C. Wright Epstein Drangel Bazerman & James, LLP60 East 42nd Street, Suite 820New York, NY 10165UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and veterinary preparations for treating cardiovascular diseases and cancer; enzymes for cardiovascular and oncologic medical purposes; enzymes for cardiovascular and oncologic veterinary purposes; biological products, namely, heparin-derived products, heparan-sulfate mimetics, for medical purposes, and biological preparations for medical purposes; biological products, namely, heparin-derived products, heparan-sulfate mimetics for veterinary purposes, and biological preparations for veterinary purposes; additives to fodder for medical purposes; chemical-pharmaceutical preparations for the treatment of cardiovascular diseases and cancer; chemical preparations for medical purposes; chemical preparations for pharmaceutical purposes for medical purposes; chemical preparations for veterinary purposes; molecules for medical therapeutic use, namely, proteins (for instance antibodies and derivatives), peptides, nucleic acids and small synthetic molecules; diagnostic preparations for medical purposes; biological preparations for medical or veterinary purposes, and for pharmaceutical use for medical purposes; media for bacteriological cultures; nutritive substances for microorganisms for medical use; cellular preparations for medical, pharmaceutical or veterinary purposes and especially for gene therapy and for cell therapy; nutritional additives for foodstuffs and food supplements for medical useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 9, 2008OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 9, 2008OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jun 20, 2008ALIEASSIGNED TO LIE—
May 23, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 23, 2008XAECEXAMINER'S AMENDMENT ENTERED—
May 23, 2008GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 23, 2008GNEAEXAMINERS AMENDMENT E-MAILED—
May 23, 2008CNEAEXAMINERS AMENDMENT -WRITTEN—
May 19, 2008ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
May 8, 2008DETHDEATH OF INTERNATIONAL REGISTRATION—
Mar 17, 2008PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Mar 2, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 2, 2008ALIEASSIGNED TO LIE—
Feb 5, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 20, 2007ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 20, 2007REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 20, 2007TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 20, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 20, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 20, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 8, 2007RFNTREFUSAL PROCESSED BY IB—
May 22, 2007RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 22, 2007RFRRREFUSAL PROCESSED BY MPU—
May 22, 2007RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 21, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 11, 2007DOCKASSIGNED TO EXAMINER—
May 4, 2007NWAPNEW APPLICATION ENTERED—
May 3, 2007REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance